These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 25656918

  • 1. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R, Palacharla RC, Mohammed AR, Manoharan A, Ponnamaneni RK, Bhyrapuneni G.
    Chem Biol Interact; 2015 Mar 25; 230():9-20. PubMed ID: 25656918
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
    Liu S, Wang Z, Chan E, Zhao Y, Kang J, Zhang X, Tian X.
    Chem Biol Interact; 2022 Jan 25; 352():109775. PubMed ID: 34910929
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.
    Sridar C, Kenaan C, Hollenberg PF.
    Drug Metab Dispos; 2012 Dec 25; 40(12):2256-66. PubMed ID: 22936314
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
    Lau AJ, Chang TK.
    Drug Metab Dispos; 2009 Sep 25; 37(9):1931-7. PubMed ID: 19487249
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-)-deprenyl and clorgyline.
    Sharma U, Roberts ES, Hollenberg PF.
    Drug Metab Dispos; 1996 Jun 25; 24(6):669-75. PubMed ID: 8781784
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion.
    Hesse LM, von Moltke LL, Shader RI, Greenblatt DJ.
    Drug Metab Dispos; 2001 Feb 25; 29(2):100-2. PubMed ID: 11159797
    [Abstract] [Full Text] [Related]

  • 12. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine.
    Richter T, Mürdter TE, Heinkele G, Pleiss J, Tatzel S, Schwab M, Eichelbaum M, Zanger UM.
    J Pharmacol Exp Ther; 2004 Jan 25; 308(1):189-97. PubMed ID: 14563790
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human CYP2B6 by N,N',N''-triethylenethiophosphoramide is irreversible and mechanism-based.
    Richter T, Schwab M, Eichelbaum M, Zanger UM.
    Biochem Pharmacol; 2005 Feb 01; 69(3):517-24. PubMed ID: 15652242
    [Abstract] [Full Text] [Related]

  • 14. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ, Mantle TJ, Tipton KF.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3555-61. PubMed ID: 6817759
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG, Baker GB.
    J Affect Disord; 1995 Dec 13; 35(3):125-9. PubMed ID: 8749840
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6.
    Court MH, Almutairi FE, Greenblatt DJ, Hazarika S, Sheng H, Klein K, Zanger UM, Bourgea J, Patten CJ, Kwara A.
    Antimicrob Agents Chemother; 2014 Jul 13; 58(7):4145-52. PubMed ID: 24820076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.